Sequencing of PCs from NDMM patients has shown that MM is frequently dominated by RAS (43% of patients) and nuclear factor kappa B (NF-κB) pathway (17%) mutations (178). The gene discussed is NFKB1; the disease is Miyoshi myopathy.